Articles On Imugene (ASX:IMU)
Title | Source | Codes | Date |
---|---|---|---|
Newcrest share price hits 6-year low. Expert predicts more pain to come
The Newcrest Mining Limited (ASX: NCM) share price has had a really tough time in 2022. Over the last six months, itâs down by 41%. Ouch. Considering itâs one of the ASXâs biggest gold miners, thatâs a painful drop. Things are not... |
Motley Fool | IMU | 1 year ago |
Evening Report: 26 September, 2022
ShareCafeEvening Report: 26 September, 2022 by Paul Sanger Australian shares have started the week sharply lower after global equity markets tumbled on Friday. Concerns over global growth and a strengthening US dollar combined to heap pre... |
ShareCafe | IMU | 1 year ago |
Closing Bell: Small caps robbed, beaten left on side of road and hit by oncoming traffic, down 4.2%
Benchmark set to end the day down 1.5% Small caps smashed down 4.2% Greenwing up 70% on Chinese investment Look. No-one likes Monday’s except possibly the last four or five Prime Ministers. I definitely sense S Morrison and K Rudd and c... |
Stockhead | IMU | 1 year ago |
ASX Large Caps: Fresh round of risk aversion hits markets as ASX extends losses, Energy sector down 6pc
The ASX has extended its losses on Monday on risk-off sentiment Energy and Mining led the losses Two CEOs departed today After losing 4% last week, the ASX retreated another 1.45% to a 3-month low on Monday as a fresh round of risk aver... |
Stockhead | IMU | 1 year ago |
Lunch Report: 26 September, 2022
ShareCafeLunch Report: 26 September, 2022 by Paul Sanger Australian shares have started the week sharply lower after global equity markets tumbled on Friday. At noon, the S&P/ASX 200 is 1.57 per cent or 103.50 points lower at 6471.20.... |
ShareCafe | IMU | 1 year ago |
Stocks of the Hour: 26 September, 2022
ShareCafeStocks of the Hour: 26 September, 2022 Arovella Therapeutics (ASX:ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform for cancer treatment, today announce... |
ShareCafe | IMU | 1 year ago |
Why the ‘outlook presents challenges’ for Zip shares: expert
The Zip Co Ltd (ASX: ZIP) share price is avoiding the worst of a brutal sell-off today. Though, the bigger picture potential for this ASX buy now, pay later (BNPL) share could be unflattering. Amid the broad and heavy selling, Zip shares... |
Motley Fool | IMU | 1 year ago |
Top 10 at 10: This is a pretty big lithium deal
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | IMU | 1 year ago |
Link share price crashes 11% after takeover collapse
The Link Administration Holdings Ltd (ASX: LNK) share price is falling again on Monday. In early trade, the administration services companyâs shares are down 11% to $2.93. This means the Link share price has now dropped 33% since this ti... |
Motley Fool | IMU | 1 year ago |
Arovella Therapeutics (ASX:ALA) collaborates with Imugene (ASX:IMU) to target solid cancers in combined trial
Arovella Therapeutics (ALA) partners with Imugene (IMU) to conduct a pre-clinical trial to target solid cancers The trial will see Arovella’s CAR19-iNKT cell therapy used in combination with Imugene’s onCARlytics platform to seek and destro... |
themarketherald.com.au | IMU | 1 year ago |
The market has been hating on this ASX 200 share in 2022. Here’s why I still love it
One of my worst performers in my ASX share portfolio this year has been Newcrest Mining Ltd (ASX: NCM). Newcrest, the largest ASX 200 gold miner on the share market, has had a shocker in recent years. Not only have Newcrest shares suffered... |
Motley Fool | IMU | 1 year ago |
5 things to watch on the ASX 200 on Friday
On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was well and truly out of form and sank deep into the red. The benchmark index dropped 1.6% to 6,700.2 points. Will the market be able to bounce back from this on Friday and end the week... |
Motley Fool | IMU | 1 year ago |
8 ASX 200 shares got kicked out of the index on Monday. How are they tracking?
The S&P/ASX 200 Index (ASX: XJO) waved farewell to eight companies on Monday morning. The benchmark index also welcomed eight others. The shakeup was part of the S&P Dow Jones Indices quarterly rebalance, which seeks to maintain r... |
Motley Fool | IMU | 1 year ago |
Closing Bell: ASX in full retreat as US traders assume best positions for looming Federal rates decision
ASX 200 down 1.6% Small caps short 1.3% Real Estate stocks hit ahead of FOMC meet The benchmark killed Tuesday only to find its very own number was up today. The ASX 200 has spent the session retracing yesterday’s 1.3% gains – driven b... |
Stockhead | IMU | 1 year ago |
ASX 200 ends in red; Materials and Utilities lead losses
Highlights: The S&P/ASX 200 closed down on Wednesday (21 September 2022), losing 1.56% to 6,700.20. The benchmark index has lost 1.88% in the last five trading days and is down 7.89% over the last 52 weeks. All eleven sectors ende... |
Kalkine Media | IMU | 1 year ago |
ASX Large Caps: Gold miners lead selloff as high USD and rates test gold price; Whitehaven at all time high
The ASX 200 fell 1.60% to a 2-month low on Wednesday Gold miners, Tech and Real Estate were hit hardest The ASX will be closed on Thursday, but the Fed decision is due at 4am AEST The ASX 200 gave up yesterday’s gains as it tumbled 1.6%... |
Stockhead | IMU | 1 year ago |
Why Imugene, Link, Newcrest, and Zip shares are dropping
The S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is on course to end the day deep in the red. At the time of writing, the benchmark index is down 1.6% to 6,699.2 points. Four ASX shares that are falling more t... |
Motley Fool | IMU | 1 year ago |
Lunch Report: 21 September, 2022
ShareCafeLunch Report: 21 September, 2022 by Paul Sanger Australian shares have dropped in morning trade, ahead of a US Federal Reserve meeting which is likely to result in another large interest rate hike. At noon, the S&P/ASX 200 is... |
ShareCafe | IMU | 1 year ago |
Imugene (ASX:IMU) doses first patient in IV cohort of VAXINIA trial
Imugene (IMU) doses the first patient in the intravenous cohort of its VAXINIA phase one clinical trialThe trial is evaluating the safety of VAXINIA, a cancer-killing virus being developed by Imugene, in patients with metastatic advanced so... |
themarketherald.com.au | IMU | 1 year ago |
ASX Health Stocks: Telix and Imugene keep making progress on cancer studies
Telix Pharma releases positive study results for TLX101 Imugene doses first patient in Phase 1 clinical trial Final IPAX-1 study data has confirmed the safety and tolerability profile for TLX101, according to Telix Pharma (ASX:TLX). The s... |
Stockhead | IMU | 1 year ago |
ASX in red; Santos slams Barossa ruling
The ASX closed 1.6 per cent lower to a two-month low amid jitters about the fallout of the next US rate hike. Imugene, Sayona Mining and Champion Iron lead the losses. Still, Soul Patts and Viva Energy found strong support. |
The Australian | IMU | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) rebounded from its recent suffering, driven higher by mining giants on Tuesday. The index closed 1.29% higher at 6,806.40 points today. Mining stocks led the pack today, with the S&P/ASX 200 Materi... |
Motley Fool | IMU | 1 year ago |
ASX Close: Interest rate worries drag index to two-month low
The share market fell to a two-month low as investors braced for another jumbo US rate hike. The S&P/ASX 200 dropped 19 points or 0.28 per cent to 6719.9, its weakest close since July 19. Gains in real estate investment trusts and... |
themarketherald.com.au | IMU | 1 year ago |
ASX Update: Miners resist tide as shares touch two-month low
A holiday-shortened trading week got off to a downbeat start as gains in mining and property stocks were outweighed by declines across the wider market. The S&P/ASX 200 reached mid-session six points or 0.1 per cent in the red. The i... |
themarketherald.com.au | IMU | 1 year ago |
Imugene (ASX:IMU) granted DIR licence to expand VAXINIA trial in Australia
Imugene (IMU) receives the DIR licence required to expand its phase one clinical trial targeting patients with metastatic or advanced solid tumours in AustraliaThe licence, granted by the Australian Government’s Office of the Gene Technolog... |
themarketherald.com.au | IMU | 1 year ago |
Imugene share price leaps 5% on trial news
The Imugene Limited (ASX: IMU) share price is shooting higher on Monday morning. At the time of writing, Imugene shares are up 4.54% to 23 cents. Whatâs driving Imugene shares higher? Investors are bidding up the Imugene share price afte... |
Motley Fool | IMU | 1 year ago |
ASX 200 rises after weak opening; Lake Resources up nearly 16%
Highlights The Australian share market opened in the red. The ASX 200 fell 0.80 points, or 0.015%, to 6,738.30 at the open. The index has lost 3.25% in the past five days. The Australian share market opened in the red... |
Kalkine Media | IMU | 1 year ago |
Why did the Imugene share price have such a lousy end to the week?
The Imugene Limited (ASX: IMU) share price finished flat for today, but has been in the red for week. At Friday’s market close, the clinical stage immuno-oncology company’s shares ended at 22 cents a pop. This means the share is down 6.38%... |
Motley Fool | IMU | 1 year ago |
Imugene Announces $80 Million Placement
On Tuesday, cancer immunotherapy developer Imugene [ASX:IMU] announced an $80 million placement to fund its clinical pipeline. The post Imugene Announces $80 Million Placement appeared first on Money Morning Australia. |
MoneyMorning | IMU | 1 year ago |
ASX Close: Peak inflation hopes lift market for fourth day
The share market sealed its longest winning run in six weeks with a fourth day of gains amid expectations tonight’s US consumer price index will confirm inflation has peaked. The S&P/ASX 200 rallied 45 points or 0.65 per cent. This... |
themarketherald.com.au | IMU | 1 year ago |
ASX Update: Commodity gains help market rise for fourth day
The share market regained 7000 as its longest win run in more than a month entered a fourth day. The S&P/ASX 200 rallied 39 points or 0.56 per cent by mid-session to 7004. On-going rebounds in crude, gold and silver lifted energy... |
themarketherald.com.au | IMU | 1 year ago |
Imugene share price sinks on $80 million cap raise
The Imugene Limited (ASX: IMU) share price has come out of a trading halt today. This comes after the clinical stage immuno-oncology company provided an update in regards to its latest capital raise. At the time of writing, Imugene shares... |
Motley Fool | IMU | 1 year ago |
Market Highlights: Wall Street jumps good, Imugene raises hard and 5 ASX small caps to watch on Tuesday
The ASX is set for a positive session Wall Street stocks surged again overnight Asian markets to close for Mid-Autumn Festival Another bouyant day of trade on Wall Street has led the local futures market higher, with the ASX 200 September... |
Stockhead | IMU | 1 year ago |
Imugene (ASX:IMU) strengthens balance sheet with $80m placement
Imugene (IMU) taps private investors for $80 million via a share placement to ensure a “long runway” of funds for its existing and future clinical programmesThe company will issue 400 million shares at 20 cents per share to institutional in... |
themarketherald.com.au | IMU | 1 year ago |
ASX 200 opens in green; Chalice Mining up nearly 7%
Highlights The Australian share market opened higher on Tuesday. The ASX 200 rose 10.40 points, or 0.15%, to 6,974.90 at the open. The index has gained 2.17% in the past five days. The Australian share market opened hi... |
Kalkine Media | IMU | 1 year ago |
Clinical trials startup HealthMatch lands $10 million Series C
Clinical trials access startup HealthMatch has raised $10 million in Series C. The round was led by the company’s original backer, Folklore Ventures. Paul Bassat’s Square Peg Capital led an $18 million Series B in the Sydney-based startup i... |
Startup Daily | IMU | 1 year ago |
Imugene (ASX:IMU) prepares to raise funds
Imugene (IMU) enters a trading halt ahead of a capital raise to facilitate investment from two new institutional investorsTrading of IMU shares will be paused until Wednesday, September 14, by which time the company should have released fur... |
themarketherald.com.au | IMU | 1 year ago |
Closing Bell: Small caps cop out, Ode to ODE’s 70pc gain, and we know why Nickel Mines is actually Nickel Industries
ASX 200 gains 1% Small Caps index does the same, but then gives it all back ODE wins and NIC MD Justin Werner: Hengjaya joins world’s best nickel resources The ASX Emerging Companies index (XEC) has given all away its early gains on Mo... |
Stockhead | IMU | 1 year ago |
Why is the Imugene share price on ice today?
The Imugene Limited (ASX: IMU) share price isnât going anywhere right now. The stock has been put into a trading halt earlier this morning pending the announcement of a capital raising. The Imugene share price last traded at 22.5 cents.... |
Motley Fool | IMU | 1 year ago |
ASX 200 ends in green; materials gains, consumer staples falls
Highlights The ASX 200 benchmark index closed up today (September 9), gaining 0.66% to 6,894.20 points. Over the last five days, the index has gained 0.96%, but is down 7.39% for the last year to date. Materials was the best performin... |
Kalkine Media | IMU | 1 year ago |
Lunch Report: 9 September, 2022
ShareCafeLunch Report: 9 September, 2022 by Paul Sanger Australian shares are on track to end the week higher after Wall Street made gains overnight. The ASX held a minute’s silence at 11am to mark the death of Queen Elizabeth II. At noon... |
ShareCafe | IMU | 1 year ago |
Why is the Lithium Power share price on ice today?
The Lithium Power International Ltd (ASX: LPI) share price is immobile today following the ASX’s decision to grant a company-requested trading pause. Before being placed on the back-burner, the Lithium Power share price has been enjoyin... |
Motley Fool | IMU | 1 year ago |
Imugene share price leaps 5% on trial news
The Imugene Ltd (ASX: IMU) share price is trading well into the green in early afternoon trade on Thursday. At the time of writing, shares in the immuno-oncology company are swapping hands at 23 cents apiece, 4.55% higher on the day.... |
Motley Fool | IMU | 1 year ago |
Why is the ResApp share price lifting today?
The ResApp Health Ltd (ASX: RAP) share price is in the green today as investors digest the latest news on Pfizer’s proposed takeover bid. Shares in the ASX healthcare company are up 0.98%, trading at 21 cents at the time of writing after s... |
Motley Fool | IMU | 1 year ago |
ASX Health Stocks: Invion proves photodynamic therapy is effective against the Zika virus
There’s a new development in the fight against the Zika virus. Invion (ASX:IVX) has just demonstrated that its Photosoft compounds were >99% effective in cell-based assays following the application of light. The study showed that Photoso... |
Stockhead | IMU | 1 year ago |
Imugene (ASX:IMU) doses first patient in phase two gastric cancer trial
Imugene (IMU) doses the first patient in its nextHERIZON phase two clinical trialThe trial is investigating its HER-Vaxx candidate when combined with other cancer treatments in patients with gastric cancerThe primary goal is to measure safe... |
themarketherald.com.au | IMU | 1 year ago |
Imugene doses first patient in nextHERIZON Phase 2 clinical trial
Clinical stage immuno-oncology company Imugene (ASX:IMU) has announced that the first patient has been dosed in the nextHERIZON Phase 2 clinical trial. |
BiotechDispatch | IMU | 1 year ago |
ASX 200 closes in green; energy leads gain, telecom services falls
Highlights The ASX 200 benchmark index closed up today (5 September), gaining 0.34% to end at 6,852.20 points. Over the last five days, the index has lost 1.63% and it has plunged 8.92% over the last 52 weeks. Energy was the best perf... |
Kalkine Media | IMU | 1 year ago |
ASX Large Caps: Local shares up; and here are the winners and losers in the ASX rebalance
The ASX finishes higher on Monday Energy / Resource only outperforming sectors ASX 200 quarterly rebalance sees 8 stocks in and 8 stocks out of the index The ASX ended Monday higher by 0.2% and trimmed last week’s losses despite a weak l... |
Stockhead | IMU | 1 year ago |
ASX Close: Market steadies ahead of likely rate hike
The share market steadied on the eve of an increase in interest rates as a US market holiday and a rebound in key commodities encouraged buyers. The S&P/ASX 200 bounced 23.5 points or 0.34 per cent from Friday’s five-week low. Gai... |
themarketherald.com.au | IMU | 1 year ago |